PolyCore Therapeutics is a biopharmaceutical company developing treatments for dyskinesia and cognitive impairment associated with neurodegenerative disorders. It offers G-protein-biased signaling dopamine D3 receptor agonists as a treatment for Parkinson's disease (PD) patients suffering from motor symptoms and levodopa (L-dopa) induced dyskinesia.